Impression - 2nd Global Left Atrial Appendage Occlusion Summit 2012

Posted on 06-07-12

About this lecture

The objective of the 2nd Global Left Atrial Appendage Occlusion Summit 2012 was to share ideas, thoughts and exchange experiences among experienced LAA closure devices and experts in the field of stroke prevention. It is designed to go beyond discussing the current available clinical data and aims to address the interests of various, potential, referring physicians.

Subjects related to this video

Scientific Meetings

Related video's

David Hildick Smith - What’s new: clinical data published and presented since last year

New clinical data for left atrial appendage occlusion therapy, presented & published in 2016. Includes a critical review of the Stroke Prevention section in the 2016 ESC Atrial Fibrillation guidelines.
Clinical Evidence Scientific Meetings

Matthew Price - What’s new: cost effectiveness and health economics

Why might LAA occlusion therapy be cost effective, despite a high procedural cost? This presentation is an overview of the health economics data available for left atrial appendage closure therapy.
Clinical Evidence Scientific Meetings

Per Wester - The neurologist's perspective: insights in AF-thromboembolic events prevention

The Neurologist point of view: review of the published evidence and the consensus on bleeding+stroke risk assessments in AF patients. when approaching antithrombotic therapy in AF patients. Includes uptake of the LAAO recommendation in the ESC guidelines and what that means to Neurologists. Many Cardiologists do not really know what Neurologist think and the reasoning. What it does it mean to the every day practice, and the annual number of ICH on NOAC or VKA for the average neurology practice?
Clinical Evidence Indications & Referral Patient Information
+1
To lecture overview